The company's second-quarter report showed the continuing impact of shrinking generic drug sales on the country's largest pharmacy chains.
For CFOs wanting to understand investor behavior, here's an argument that Jeff Bezos is human, after all, and Amazon can't defy basic economic principles.
The drugstore chain's pharmacy same-store sales rose 5.1% in Q2, offsetting a 2.7% drop in retail comparable sales.
The $54 billion deal is the latest move by an insurer to cut health care costs by bringing pharmacy benefits and medical claims under one roof.
Amazon is a revolutionary force, but it's a positive one for businesses and customers alike: veteran marketing exec.
The enforcement action is another sign of increased scrutiny of corporate accounting by the Securities and Exchange Commission.
Probably, but they should consult their legal teams first.
